ibrance 帕博西尼

药直供药师

药直供执业药师

摘要：IBRANCE – A Revolutionary Drug in the Fight Against Breast Cancer Breast cancer is a serious health concern for women all around the world. According to statistics, breast cancer is the most common

有用 0

浏览 181次

2023-03-29 18:57:15 发布

IBRANCE – A Revolutionary Drug in the Fight Against Breast Cancer

Breast cancer is a serious health concern for women all around the world. According to statistics, breast cancer is the most common cancer in women globally, with over 2 million new cases diagnosed every year. While there have been advances in treatment options, there is still a lot of work to be done to cure this disease. But the good news is that there could be a game-changer drug in the market – IBRANCE.

What is IBRANCE?

IBRANCE is a brand name for the drug palbociclib. Palbociclib is a type of targeted therapy that is used in combination with other drugs to treat advanced breast cancer in postmenopausal women. It works by blocking enzymes called cyclin-dependent kinase 4 and 6 (CDK4/6), which promote the growth of cancer cells. It has been shown to significantly slow down the progression of advanced breast cancer.

Why is it So Revolutionary?

IBRANCE is revolutionary because it is one of the few drugs approved by the FDA that specifically targets certain genetic mutations found in breast cancer. Additionally, it was the first CDK4/6 inhibitor to be approved by the FDA, making it a groundbreaking drug.

Clinical Trials

In clinical trials, palbociclib was used in combination with an aromatase inhibitor (a type of medication used to treat breast cancer) and was shown to be effective in slowing down the progression of cancer in women with advanced breast cancer. In one trial, the median progression-free survival (PFS) for patients who received palbociclib was 20.2 months, compared to 10.2 months for patients who received a placebo.

Side Effects

Like all drugs, palbociclib does have some side effects, although they are typically manageable. The most common side effects include:

- Fatigue

- Nausea

- Diarrhea

- Low white blood cell count (meaning an increased risk of infection)

Conclusion

IBRANCE is a remarkable drug that has shown positive results in the treatment of advanced breast cancer in postmenopausal women. It has been shown to be effective in slowing down the progression of cancer, and it is easy to manage its side effects. While there is still work to be done to completely cure breast cancer, IBRANCE is a significant step in the right direction, and it gives hope to patients and doctors alike.

帕博西尼的相关介绍

乳腺癌

说明书

注：本站所有内容仅供参考，不代表药直供立场(如有错漏，请帮忙指正)，转载请注明出处。不作为诊断及治疗依据，不可替代专业医师诊断、不可替代医师处方。本站不承担由此导致的相关责任！

2023-03-29 18:57:15 更新

帕博西尼基本信息
帕博西尼
- 剂型：
  片剂
- 厂家：
  印度卢修斯
- 适应症：
  治疗晚期转移性乳腺癌，显著延长中位无进展生存期
帕博西尼基本信息
帕博西尼
- 剂型：
  片剂
- 厂家：
  孟加拉伊思达
- 适应症：
  治疗晚期转移性乳腺癌，显著延长中位无进展生存期
帕博西尼基本信息
帕博西尼
- 剂型：
  片剂
- 厂家：
  孟加拉碧康制药
- 适应症：
  治疗晚期转移性乳腺癌，显著延长中位无进展生存期
帕博西尼基本信息
帕博西尼
- 剂型：
  片剂
- 厂家：
  孟加拉耀品国际
- 适应症：
  治疗晚期转移性乳腺癌，显著延长中位无进展生存期
帕博西尼 Palbociclib Parcini基本信息
帕博西尼 Palbociclib Parcini
- 剂型：
  胶囊
- 厂家：
  老挝东盟制药
- 适应症：
  治疗晚期转移性乳腺癌，显著延长中位无进展生存期